The Use of Vitamin K2 in Patients With Parkinson's Disease and Mitochondrial Dysfunction (PD-K2): A Theranostic Pilot Study in a Placebo-Controlled Parallel Group Design

The Use of Vitamin K2 in Patients With Parkinson's Disease and Mitochondrial Dysfunction (PD-K2): A Theranostic Pilot Study in a Placebo-Controlled Parallel Group Design

Background: Despite rapid advances in research on Parkinson's disease (PD), in particular in the elucidation of genetic contributions, no disease-modifying therapy has become available to date.Objectives: In the proposed project, we aim to investigate the potential effects of vitamin K2 (long-c...

Full description

Bibliographic Details
Main Authors: Jannik Prasuhn, Meike Kasten, Melissa Vos, Inke R. König, Sebastian M. Schmid, Britta Wilms, Christine Klein, Norbert Brüggemann
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Neurology
Subjects:
Parkinson's disease
treatments
vitamin K2
Parkin (PARK2)
PINK1
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2020.592104/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2020.592104/full

Similar Items